AIM IMMUNOTECH INC. Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31)
AIM IMMUNOTECH INC. (AIM) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) of $131.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax · last filed 2013-11-08
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2013-09-30 was $131.00K.
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2013-06-30 was -$77.00K.
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was -$10.00K.
- AIM IMMUNOTECH INC. other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, net of tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$168.00K, a 1300.00% decline year-over-year.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax (Deprecated 2013-01-31) 9 month |
|---|---|---|---|
| 2013-09-30 | $131.00K 10-Q · filed 2013-11-08 | $54.00K derived: sum of 2 quarters · filed 2013-11-08 | $44.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$77.00K 10-Q · filed 2013-08-09 | -$87.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$10.00K 10-Q · filed 2013-05-08 | ||
| 2012-09-30 | -$168.00K 10-Q · filed 2013-11-08 | -$189.00K derived: sum of 2 quarters · filed 2013-11-08 | -$205.00K 10-Q · filed 2013-11-08 |
| 2012-06-30 | -$21.00K 10-Q · filed 2013-08-09 | -$37.00K 10-Q · filed 2013-08-09 | |
| 2012-03-31 | -$16.00K 10-Q · filed 2013-05-08 | ||
| 2011-09-30 | $14.00K 10-Q · filed 2012-11-02 | -$927.00K derived: sum of 2 quarters · filed 2012-11-02 | $509.00K 10-Q · filed 2012-11-02 |
| 2011-06-30 | -$941.00K 10-Q · filed 2012-08-08 | -$495.00K 10-Q · filed 2012-08-08 | |
| 2011-03-31 | $13.00K 10-Q · filed 2012-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |